tradmap

GENB Generate Biomedicines, Inc.

$14.48 +4.55%

Healthcare · Pharmaceutical Preparations

Generate Biomedicines, Inc. (GENB) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.9 billion. Shares last traded at $14.48, 32.1% below their 52-week high.

Market Cap
$1.9B
Shares Out
128.2M
EPS (TTM)
P/E Ratio
P/S Ratio
P/B Ratio
Dividend / Share
Dividend Yield
52-Week High
$21.34
52-Week Low
$11.00
Volume
19,488
Avg Vol (3m)
26,499.635

Performance

1W
+12.42%
1M
+16.59%
3M
+17.96%
6M
YTD
+12.73%
1Y

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
56.63
SMA (50)
$13.35
SMA (200)
Price vs SMA50
+8.50%
Price vs SMA200
ATR (14)
$1.13

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $-1.07 2026-05-07
Q1 2026 $-1.62 2026-05-07

Full earnings history →

Pharmaceutical Preparations peers

GENB vs 14 industry peers (Pharmaceutical Preparations), by market cap.

1–14 of 14
LLYLilly (Eli)$1.04T50.1615.8831.7%-1.17%
JNJJohnson & Johnson$549.8B20.515.8428.5%-2.42%
ONCBeone Medicines Ltd.$390.6B1361.2673.105.4%+2.83%
ABBVAbbVie$382.5B90.516.256.9%-2.16%
MRKMerck$281.6B15.434.3328.1%-1.30%
ABTAbbott Laboratories$154.3B23.653.4814.7%+0.09%
PFEPfizer$143.7B18.502.3012.4%-2.89%
VRTXVertex Pharmaceuticals$114.6B28.999.5532.9%-1.63%
BMYBristol Myers Squibb$110.3B15.632.2914.6%-2.35%
REGNRegeneron Pharmaceuticals$63.4B14.084.4231.4%+0.38%
ALNYAlnylam Pharmaceuticals$36.9B117.579.938.4%-1.66%
TEVATeva Pharmaceutical Industries Ltd$36.6B25.982.128.2%-3.33%
ZTSZoetis$33.1B12.373.4928.2%+2.09%
RPRXRoyalty Pharma Plc$23.1B30.029.7332.4%-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.